2/4
11:03 am
ctmx
Rating for CTMX
Low
Report
Rating for CTMX
2/4
09:12 am
ctmx
Rating for CTMX
Medium
Report
Rating for CTMX
2/4
09:12 am
ctmx
Rating for CTMX
Medium
Report
Rating for CTMX
1/21
06:19 am
ctmx
CytomX Therapeutics (NASDAQ:CTMX) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
Low
Report
CytomX Therapeutics (NASDAQ:CTMX) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
1/21
06:19 am
ctmx
CytomX Therapeutics (NASDAQ:CTMX) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
Low
Report
CytomX Therapeutics (NASDAQ:CTMX) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
1/20
11:41 am
ctmx
Rating for CTMX
Low
Report
Rating for CTMX
1/20
11:41 am
ctmx
Rating for CTMX
Low
Report
Rating for CTMX
1/20
09:03 am
ctmx
Rating for CTMX
Low
Report
Rating for CTMX
1/20
09:03 am
ctmx
Rating for CTMX
Low
Report
Rating for CTMX
1/20
07:17 am
ctmx
CytomX Therapeutics (NASDAQ:CTMX) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
CytomX Therapeutics (NASDAQ:CTMX) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
1/20
07:17 am
ctmx
CytomX Therapeutics (NASDAQ:CTMX) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
Low
Report
CytomX Therapeutics (NASDAQ:CTMX) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
1/20
07:17 am
ctmx
CytomX Therapeutics (NASDAQ:CTMX) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
Low
Report
CytomX Therapeutics (NASDAQ:CTMX) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
1/20
06:48 am
ctmx
CytomX Therapeutics initiated with a Buy at Guggenheim
Low
Report
CytomX Therapeutics initiated with a Buy at Guggenheim
1/20
06:48 am
ctmx
CytomX Therapeutics initiated with a Buy at Guggenheim
Low
Report
CytomX Therapeutics initiated with a Buy at Guggenheim
11/7
11:30 pm
ctmx
CytomX Therapeutics (NASDAQ:CTMX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.
High
Report
CytomX Therapeutics (NASDAQ:CTMX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.
11/7
11:30 pm
ctmx
CytomX Therapeutics (NASDAQ:CTMX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.
High
Report
CytomX Therapeutics (NASDAQ:CTMX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.